Curtis Balch

1.1k total citations
14 papers, 836 citations indexed

About

Curtis Balch is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Curtis Balch has authored 14 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Cancer Research and 1 paper in Surgery. Recurrent topics in Curtis Balch's work include Epigenetics and DNA Methylation (8 papers), Histone Deacetylase Inhibitors Research (5 papers) and MicroRNA in disease regulation (3 papers). Curtis Balch is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Histone Deacetylase Inhibitors Research (5 papers) and MicroRNA in disease regulation (3 papers). Curtis Balch collaborates with scholars based in United States, United Kingdom and Taiwan. Curtis Balch's co-authors include Kenneth P. Nephew, Robert Brown, Tim H.‐M. Huang, Meng Li, John Dedman, Seungyoon Nam, Sun Kim, Kwangmin Choi, Tim H-M. Huang and Pearlly S. Yan and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Bioinformatics.

In The Last Decade

Curtis Balch

14 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Curtis Balch United States 13 714 283 93 66 59 14 836
Azat Garipov United States 6 679 1.0× 204 0.7× 182 2.0× 83 1.3× 42 0.7× 6 837
Caroline Barton Australia 8 362 0.5× 175 0.6× 123 1.3× 83 1.3× 32 0.5× 9 501
Irene K. Guttilla Reed United States 10 720 1.0× 577 2.0× 191 2.1× 18 0.3× 52 0.9× 13 902
Corrado Caslini United States 14 746 1.0× 99 0.3× 139 1.5× 20 0.3× 46 0.8× 20 937
Dazhong Zhuang United States 9 427 0.6× 138 0.5× 135 1.5× 59 0.9× 83 1.4× 12 639
Sebastian Kehrloesser Germany 13 574 0.8× 194 0.7× 374 4.0× 52 0.8× 46 0.8× 15 771
Jude M. Mulligan United Kingdom 9 346 0.5× 148 0.5× 200 2.2× 76 1.2× 176 3.0× 14 555
Dragana Kopanja United States 16 624 0.9× 136 0.5× 230 2.5× 20 0.3× 50 0.8× 20 739
Huaizeng Chen China 16 514 0.7× 165 0.6× 280 3.0× 124 1.9× 42 0.7× 44 788
Bernard Leroy France 10 453 0.6× 287 1.0× 396 4.3× 31 0.5× 64 1.1× 10 747

Countries citing papers authored by Curtis Balch

Since Specialization
Citations

This map shows the geographic impact of Curtis Balch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtis Balch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtis Balch more than expected).

Fields of papers citing papers by Curtis Balch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curtis Balch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtis Balch. The network helps show where Curtis Balch may publish in the future.

Co-authorship network of co-authors of Curtis Balch

This figure shows the co-authorship network connecting the top 25 collaborators of Curtis Balch. A scholar is included among the top collaborators of Curtis Balch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curtis Balch. Curtis Balch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Matei, Daniela, Fujin Fang, Jeanne M. Schilder, et al.. (2011). A phase II study of decitabine and carboplatin in recurrent platinum (Pt)-resistant ovarian cancer (OC).. Journal of Clinical Oncology. 29(15_suppl). 5011–5011. 12 indexed citations
2.
Balch, Curtis & Kenneth P. Nephew. (2011). The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer. Cancer Biomarkers. 8(4-5). 203–221. 13 indexed citations
3.
Hahn, Noah M., Patty L. Bonney, Deepika Dhawan, et al.. (2011). Subcutaneous 5-Azacitidine Treatment of Naturally Occurring Canine Urothelial Carcinoma: A Novel Epigenetic Approach to Human Urothelial Carcinoma Drug Development. The Journal of Urology. 187(1). 302–309. 35 indexed citations
4.
Balch, Curtis, Daniela Matei, Tim H-M. Huang, & Kenneth P. Nephew. (2010). Role of Epigenomics in Ovarian and Endometrial Cancers. Epigenomics. 2(3). 419–447. 35 indexed citations
5.
Nam, Seungyoon, Meng Li, Kwangmin Choi, et al.. (2009). MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression. Nucleic Acids Research. 37(suppl_2). W356–W362. 137 indexed citations
6.
Chan, Michael WY, Sandya Liyanarachchi, Curtis Balch, et al.. (2009). An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Systems Biology. 3(1). 73–73. 54 indexed citations
7.
Abbosh, Philip H., Jason A. Starkey, Miloš V. Novotný, et al.. (2006). Dominant-Negative Histone H3 Lysine 27 Mutant Derepresses Silenced Tumor Suppressor Genes and Reverses the Drug-Resistant Phenotype in Cancer Cells. Cancer Research. 66(11). 5582–5591. 82 indexed citations
8.
Wei, Susan, Curtis Balch, Henry Paik, et al.. (2006). Prognostic DNA Methylation Biomarkers in Ovarian Cancer. Clinical Cancer Research. 12(9). 2788–2794. 118 indexed citations
9.
Li, Lang, Alfred S.L. Cheng, Victor X. Jin, et al.. (2006). A mixture model-based discriminate analysis for identifying ordered transcription factor binding site pairs in gene promoters directly regulated by estrogen receptor-α. Bioinformatics. 22(18). 2210–2216. 11 indexed citations
10.
Balch, Curtis, Pearlly S. Yan, Teresa Craft, et al.. (2005). Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer. Molecular Cancer Therapeutics. 4(10). 1505–1514. 110 indexed citations
11.
Balch, Curtis, Tim H.‐M. Huang, Robert Brown, & Kenneth P. Nephew. (2004). The epigenetics of ovarian cancer drug resistance and resensitization. American Journal of Obstetrics and Gynecology. 191(5). 1552–1572. 128 indexed citations
12.
Campos, Begoña, Tanya R. Mealy, Manal A. Swairjo, et al.. (1998). Mutational and Crystallographic Analyses of Interfacial Residues in Annexin V Suggest Direct Interactions with Phospholipid Membrane Components,. Biochemistry. 37(22). 8004–8010. 38 indexed citations
13.
Balch, Curtis & John Dedman. (1997). Annexins II and V Inhibit Cell Migration. Experimental Cell Research. 237(2). 259–263. 39 indexed citations
14.
Balch, Curtis, et al.. (1994). The use of N-(7-nitrobenz-2-oxa-1,3-diazole-4-yl)-labeled lipids in determining transmembrane lipid distribution. Chemistry and Physics of Lipids. 70(2). 205–212. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026